Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more
May 09, 2017 edition of the weekly JAMA Editors' Summary
Source: JAMA: This Week's Audio Commentary - Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
More News: American Medical Association (AMA) | Cancer | Cancer & Oncology | General Medicine | Lung Cancer | Thyroid | Thyroid Cancer